117 related articles for article (PubMed ID: 38126199)
1. Single-Cell RNA Sequencing Reveals Metabolic Stress-Dependent Activation of Cardiac Macrophages in a Model of Dyslipidemia-Induced Diastolic Dysfunction.
Panico C; Felicetta A; Kunderfranco P; Cremonesi M; Salvarani N; Carullo P; Colombo F; Idini A; Passaretti M; Doro R; Rubino M; Villaschi A; Da Rin G; Peano C; Kallikourdis M; Greco CM; Condorelli G
Circulation; 2023 Dec; ():. PubMed ID: 38126199
[TBL] [Abstract][Full Text] [Related]
2. CXCR4-dependent macrophage-to-fibroblast signaling contributes to cardiac diastolic dysfunction in heart failure with preserved ejection fraction.
Zhang N; Ma Q; You Y; Xia X; Xie C; Huang Y; Wang Z; Ye F; Yu Z; Xie X
Int J Biol Sci; 2022; 18(3):1271-1287. PubMed ID: 35173552
[No Abstract] [Full Text] [Related]
3. Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction.
Zhang N; Feng B; Ma X; Sun K; Xu G; Zhou Y
Cardiovasc Diabetol; 2019 Aug; 18(1):107. PubMed ID: 31429767
[TBL] [Abstract][Full Text] [Related]
4. Cell therapy attenuates endothelial dysfunction in hypertensive rats with heart failure and preserved ejection fraction.
de Couto G; Mesquita T; Wu X; Rajewski A; Huang F; Akhmerov A; Na N; Wu D; Wang Y; Li L; Tran M; Kilfoil P; Cingolani E; Marbán E
Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H892-H903. PubMed ID: 36083797
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a robust mouse model of heart failure with preserved ejection fraction.
Matsiukevich D; Kovacs A; Li T; Kokkonen-Simon K; Matkovich SJ; Oladipupo SS; Ornitz DM
Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H203-H231. PubMed ID: 37204871
[TBL] [Abstract][Full Text] [Related]
6. Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA-HFpEF trial.
Scheffer M; Driessen-Waaijer A; Hamdani N; Landzaat JWD; Jonkman NH; Paulus WJ; van Heerebeek L
ESC Heart Fail; 2020 Dec; 7(6):4478-4487. PubMed ID: 33073523
[TBL] [Abstract][Full Text] [Related]
7. HMGB1-Promoted Neutrophil Extracellular Traps Contribute to Cardiac Diastolic Dysfunction in Mice.
Zhang XL; Wang TY; Chen Z; Wang HW; Yin Y; Wang L; Wang Y; Xu B; Xu W
J Am Heart Assoc; 2022 Feb; 11(4):e023800. PubMed ID: 35156391
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects on the development of heart failure with preserved ejection fraction by the sodium-glucose cotransporter 2 inhibitor dapagliflozin in type 2 diabetes.
Feng B; Yu P; Yu H; Qian B; Li Y; Sun K; Shi B; Zhang N; Xu G
Diabetol Metab Syndr; 2023 Jun; 15(1):141. PubMed ID: 37386620
[TBL] [Abstract][Full Text] [Related]
9. A Preclinical Rat Model of Heart Failure With Preserved Ejection Fraction With Multiple Comorbidities.
Hubesch G; Hanthazi A; Acheampong A; Chomette L; Lasolle H; Hupkens E; Jespers P; Vegh G; Wembonyama CWM; Verhoeven C; Dewachter C; Vachiery JL; Entee KM; Dewachter L
Front Cardiovasc Med; 2021; 8():809885. PubMed ID: 35097026
[TBL] [Abstract][Full Text] [Related]
10. Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway.
Ni XY; Feng XJ; Wang ZH; Zhang Y; Little PJ; Cao Y; Xu SW; Tang LQ; Weng JP
Acta Pharmacol Sin; 2024 Apr; ():. PubMed ID: 38589689
[TBL] [Abstract][Full Text] [Related]
11. Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction.
Packer M
J Card Fail; 2019 Dec; 25(12):986-1003. PubMed ID: 31541742
[TBL] [Abstract][Full Text] [Related]
12. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
13. Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease pathogenesis.
Glezeva N; Voon V; Watson C; Horgan S; McDonald K; Ledwidge M; Baugh J
J Card Fail; 2015 Feb; 21(2):167-77. PubMed ID: 25459685
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction.
Zhang L; Chen J; Yan L; He Q; Xie H; Chen M
Front Pharmacol; 2021; 12():646240. PubMed ID: 34177571
[No Abstract] [Full Text] [Related]
15. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
[TBL] [Abstract][Full Text] [Related]
16. Salvianolic acid A alleviates heart failure with preserved ejection fraction via regulating TLR/Myd88/TRAF/NF-κB and p38MAPK/CREB signaling pathways.
Dawuti A; Sun S; Wang R; Gong D; Liu R; Kong D; Yuan T; Zhou J; Lu Y; Wang S; Du G; Fang L
Biomed Pharmacother; 2023 Dec; 168():115837. PubMed ID: 37931518
[TBL] [Abstract][Full Text] [Related]
17. Diabetes and Excess Aldosterone Promote Heart Failure With Preserved Ejection Fraction.
Hegyi B; Mira Hernandez J; Ko CY; Hong J; Shen EY; Spencer ER; Smoliarchuk D; Navedo MF; Bers DM; Bossuyt J
J Am Heart Assoc; 2022 Dec; 11(23):e027164. PubMed ID: 36416174
[TBL] [Abstract][Full Text] [Related]
18. Cardiac sympathetic overdrive, M2 macrophage activation and fibroblast heterogeneity are associated with cardiac remodeling in a chronic pressure overload rat model of HFpEF.
Sun F; Yuan L; Wang Z; Cui X; Lv N; Zhang T; Zhang Y; Cai J
Front Pharmacol; 2024; 15():1364758. PubMed ID: 38860171
[TBL] [Abstract][Full Text] [Related]
19. NLRP3-inflammasome inhibition by MCC950 attenuates cardiac and pulmonary artery remodelling in heart failure with preserved ejection fraction.
Cheng X; Zhao H; Wen X; Li G; Guo S; Zhang D
Life Sci; 2023 Nov; 333():122185. PubMed ID: 37858713
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway.
Yousefi K; Irion CI; Takeuchi LM; Ding W; Lambert G; Eisenberg T; Sukkar S; Granzier HL; Methawasin M; Lee DI; Hahn VS; Kass DA; Hatzistergos KE; Hare JM; Webster KA; Shehadeh LA
J Am Coll Cardiol; 2019 Jun; 73(21):2705-2718. PubMed ID: 31146816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
